GL1X · GenesisL1 explorer

Ligand · ULY

ULY · 4-{8-amino-3-[(6r,8as)-3-oxo-3,5,6,7,8,8A-hexahydroindolizin-6-yl]imidazo[1,5-a]pyrazin-1-yl}-3-methoxy-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide

ULY, 4-{8-amino-3-[(6r,8as)-3-oxo-3,5,6,7,8,8A-hexahydroindolizin-6-yl]imidazo[1,5-a]pyrazin-1-yl}-3-methoxy-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide (C28 H26 F3 N7 O3, 565.6 g/mol), in the MolNFT structures on GenesisL1: bound in 1…

Component
ULY
Formula
C28 H26 F3 N7 O3
Class
ligand
Structures
1
PDB entries
1

Binding sites

ULY in 1 structure; the first of them:

  • 6X3O · Co-structure of btk kinase domain with L-005191930 inhibitor · ULY A701 · binds LEU408, GLY409, THR410, GLY411, VAL416, ALA428, ILE429, LYS430 and 17 more

Residues it binds most

LEU 2, GLY 2, ALA 2, ILE 2, MET 2, PHE 2, THR 2, ASN 2, ASP 2, CYS 2 (residue and the binding sites it lines).

Found with

  • 5WE · 4-[8-azanyl-3-[(2~{S})-1-[4-(dimethylamino) butanoyl]pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-~{N}-(1,3-thiazol-2-yl)benzamide

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.